323 related articles for article (PubMed ID: 16087719)
1. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719
[TBL] [Abstract][Full Text] [Related]
2. The action of GLP-1 and exendins upon glucose transport in normal human adipocytes, and on kinase activity as compared to morbidly obese patients.
Sancho V; Nuche B; Arnés L; Cancelas J; González N; Díaz-Miguel M; Martín-Duce A; Valverde I; Villanueva-Peñacarrillo ML
Int J Mol Med; 2007 Jun; 19(6):961-6. PubMed ID: 17487430
[TBL] [Abstract][Full Text] [Related]
3. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
González N; Acitores A; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
Regul Pept; 2005 Mar; 126(3):203-11. PubMed ID: 15664668
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.
Arnés L; González N; Tornero-Esteban P; Sancho V; Acitores A; Valverde I; Delgado E; Villanueva-Peñacarrillo ML
Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785
[TBL] [Abstract][Full Text] [Related]
5. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle.
Acitores A; González N; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
J Endocrinol; 2004 Mar; 180(3):389-98. PubMed ID: 15012593
[TBL] [Abstract][Full Text] [Related]
6. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
[TBL] [Abstract][Full Text] [Related]
7. Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle.
Acitores A; González N; Sancho V; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
Horm Metab Res; 2005 May; 37(5):275-80. PubMed ID: 15971149
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
[TBL] [Abstract][Full Text] [Related]
9. Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects.
Sancho V; Trigo MV; Martín-Duce A; Gonz Lez N; Acitores A; Arnés L; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
Int J Mol Med; 2006 Jun; 17(6):1133-7. PubMed ID: 16685426
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
11. Effect of GLP-1 on lipid metabolism in human adipocytes.
Villanueva-Peñacarrillo ML; Márquez L; González N; Díaz-Miguel M; Valverde I
Horm Metab Res; 2001 Feb; 33(2):73-7. PubMed ID: 11294496
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1.
Idris I; Patiag D; Gray S; Donnelly R
Biochem Pharmacol; 2002 Mar; 63(5):993-6. PubMed ID: 11911852
[TBL] [Abstract][Full Text] [Related]
13. GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients.
González N; Sancho V; Martín-Duce A; Tornero-Esteban P; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
Int J Mol Med; 2005 Oct; 16(4):747-52. PubMed ID: 16142415
[TBL] [Abstract][Full Text] [Related]
14. Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients.
Villanueva-Peñacarrillo ML; Martín-Duce A; Ramos-Álvarez I; Gutiérrez-Rojas I; Moreno P; Nuche-Berenguer B; Acitores A; Sancho V; Valverde I; González N
Regul Pept; 2011 Jun; 168(1-3):39-44. PubMed ID: 21419173
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.
Luque MA; González N; Márquez L; Acitores A; Redondo A; Morales M; Valverde I; Villanueva-Peñacarrillo ML
J Endocrinol; 2002 Jun; 173(3):465-73. PubMed ID: 12065236
[TBL] [Abstract][Full Text] [Related]
16. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
Villanueva-Peñacarrillo ML; Puente J; Redondo A; Clemente F; Valverde I
Endocrine; 2001 Jul; 15(2):241-8. PubMed ID: 11720253
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats.
López-Delgado MI; Morales M; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I
Endocrinology; 1998 Jun; 139(6):2811-7. PubMed ID: 9607788
[TBL] [Abstract][Full Text] [Related]
18. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B
Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue.
Perea A; Viñambres C; Clemente F; Villanueva-Peñacarrillo ML; Valverde I
Horm Metab Res; 1997 Sep; 29(9):417-21. PubMed ID: 9370107
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
